Abstract

A vaccine for hepatitis B became available in the UK from 1982, but it did not solve the public health dilemmas presented by the disease. In the decade that followed, epidemiologically important groups such as intravenous drug users and gay men were not targetted, while the groups of health workers at the centre of policy concern received little vaccine. This paper draws on models of diffusion, the pattern of the disease, and previous policies on screening, to explain the restricted vaccine policy which was a field for contention through the 1980s and into the 1990s